- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:46 | Financière de Tubize SA: Financière de Tubize - Dividend approval | 92 | GlobeNewswire (Europe) | Dividend confirmationRegulated information - 24 April 2026
The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of... ► Artikel lesen | |
| 19:34 | Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings? | 2 | Zacks | ||
| 19:34 | ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? | 2 | Zacks | ||
| 19:26 | Dr. Reddy's Laboratories (RDY) Announces Rollout of Injectable Semaglutide Under Brand Name Obeda | 1 | Insider Monkey | ||
| 19:25 | Hauptversammlung: Für Bayer kommen jetzt entscheidende Wochen | 34 | FAZ | ||
| 18:54 | Edwards Lifesciences Stock Surges On Heart Valve Devices Growth | 3 | Benzinga.com | ||
| 18:54 | Happy Belly Food Group Inc: Happy Belly to open Heal Wellness store in Toronto | 2 | Stockwatch | ||
| 18:46 | Sanofi MS drug rejected in US gets an endorsement in Europe | 3 | BioPharma Dive | ||
| 18:35 | Wall Street Says Buy Merck Over Pfizer. The Numbers Tell a More Complicated Story. | 5 | Barchart.com | ||
| 18:29 | ADVICENNE: Advicenne 2025 Universal Registration Document made available | 1 | Euronext | ||
| 18:26 | Pfizer Inc. (PFE): One of the Best Safe Stocks to Invest in for Beginners | 8 | Insider Monkey | ||
| 18:18 | Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change | 1 | Benzinga.com | ||
| 18:10 | Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval | 2 | FiercePharma | ||
| 18:10 | NVO Reports Strong Phase III Diabetes Data for Children & Adolescents | 50 | Zacks | ||
| 18:10 | FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs | 7 | FiercePharma | ||
| 18:06 | Advicenne 2025 Universal Registration Document Made Available | 196 | Business Wire | Regulatory News:
Advicenne (Euronext Growth Paris FR0013296746 ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from... ► Artikel lesen | |
| 17:58 | Gedeon Richter Plc.: Extraordinary Information | - | Budapest Stock Exchange | ||
| 17:48 | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | 331 | AFX News | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen | |
| 17:48 | Bristol, Pfizer's Eliquis becoming available on Mark Cuban Cost Plus Drug | 5 | Seeking Alpha | ||
| 17:46 | Lilly tumbles on Foundayo's shaky week; FDA to issue vouchers for psychedelics | 14 | BioPharma Dive |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| BAYER | 18 | 36 | -3,85 % | Bayer, MustGrow Biologics und Yara International: So holen Sie sich den 40 % Dünger-Preissprung in Ihr Portfolio | Seit Ende Februar 2026 blockiert der Iran-Krieg die Straße von Hormuz und katapultiert Stickstoffdüngerpreise um 40 % nach oben. Während geopolitische Schocks die Lieferketten zerreißen, entstehen für... ► Artikel lesen | ||
| SANOFI | 13 | 42 | -1,31 % | Entschlüsselung fehlregulierter Immunreaktionen: Forschung bei Sanofi an neuen Therapieoptionen für Autoimmunerkrankungen | Frankfurt/Main (ots) - Autoimmunerkrankungen betreffen weltweit Millionen von Patient*innen. Sie erfordern oft lebenslange Behandlung. Trotz bedeutender medizinischer Fortschritte sprechen nicht alle... ► Artikel lesen | ||
| EDWARDS LIFESCIENCES | 11 | 17 | +4,48 % | Edwards Lifesciences Corp. Q1 Income Rises | WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) released a profit for its first quarter that Increases, from the same period last yearThe company's earnings came in at $380.7 million... ► Artikel lesen | ||
| PFIZER | 10 | 92 | +0,90 % | Ihre wichtigsten Termine: Heute im Blick: SAP, Intel, Pfizer, Nestle, LVMH, American Express und Heineken! | © Foto: Bild von Andreas Lischka auf PixabayGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | ||
 | NOVO NORDISK | 10 | 40 | +6,05 % | Kailera Therapeutics-Aktie: Bekommen Eli Lilly und Novo Nordisk nun Angst? | Es ist einer der heißesten Börsengänge im Biotech-Sektor dieses Jahr. Kailera Therapeutics feiert heute sein Börsendepüt an der Nasdaq. Das Biotech-Unternehmen will mit seinen Wirkstoffen den Adipositas-Markt... ► Artikel lesen | |
| ABBVIE | 9 | 55 | -1,48 % | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen | ||
| NOVARTIS | 7 | 105 | -2,62 % | Novartis Pharma AG: Novartis receives positive CHMP opinion for Itvisma for spinal muscular atrophy (SMA) | If approved, Itvisma (intrathecal onasemnogene?abeparvovec) will be first and only gene replacement therapy for children two years and older, teens and adults with SMA in the European UnionItvisma demonstrated... ► Artikel lesen | ||
 | CHINA RESOURCES PHARMACEUTICAL | 7 | 5 | +2,34 % | CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2026 | ||
 | VISTIN PHARMA | 7 | 1 | 0,00 % | Vistin Pharma ASA: First quarter 2026 financial results | Vistin Pharma ASA: First quarter 2026 financial results Oslo, Norway, 24th of April 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2026. First quarter... ► Artikel lesen | |
| ELI LILLY | 6 | 125 | -4,19 % | Lilly tumbles on Foundayo's shaky week; FDA to issue vouchers for psychedelics |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| ELI LILLY AND COMPANY | 752,20 | 968,78 | +29 % | 1 | - | - | |||
| MERCK KGAA | 111,90 | 140,40 | +25 % | 10 | 7 | - | |||
| SCHOTT PHARMA AG & CO KGAA | 14,920 | 18,70 | +25 % | 2 | 8 | - | |||
| ASTRAZENECA PLC | 161,00 | 192,07 | +19 % | 26 | 1 | 6 | |||
| SANOFI SA | 80,72 | 94,57 | +17 % | 9 | 16 | - | |||
| BAYER AG | 38,500 | 44,71 | +16 % | 25 | 10 | 1 | |||
| ROCHE HOLDING AG PS | 352,19 | 380,37 | +8 % | 13 | 18 | 5 | |||
| NOVO NORDISK A/S | 34,965 | 37,47 | +7 % | 9 | 31 | 1 | ||
| PFIZER INC | 23,015 | 24,61 | +7 % | 1 | 4 | - | |||
| NOVARTIS AG | 123,38 | 129,57 | +5 % | 5 | 11 | 3 | |||
| GSK PLC | 23,330 | 22,73 | -3 % | 5 | 9 | 14 | |||
| DOCMORRIS AG | 7,690 | 7,39 | -4 % | 4 | 9 | 5 | |||
| DERMAPHARM HOLDING SE | 45,700 | 34 | -26 % | - | 2 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.